Achieve Life Sciences Inc (NASDAQ:ACHV) has a beta value of 1.30 and has seen 2.71 million shares traded in the recent trading session. The company, currently valued at $130.64M, closed the recent trade at $2.63 per share which meant it gained $0.31 on the day or 13.33% during that session. The ACHV stock price is -101.9% off its 52-week high price of $5.31 and 30.04% above the 52-week low of $1.84. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.37 million shares traded. The 3-month trading volume is 617.27K shares.
The consensus among analysts is that Achieve Life Sciences Inc (ACHV) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Achieve Life Sciences Inc (NASDAQ:ACHV) trade information
Sporting 13.33% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ACHV stock price touched $2.63 or saw a rise of 2.23%. Year-to-date, Achieve Life Sciences Inc shares have moved -44.18%, while the 5-day performance has seen it change 27.02%. Over the past 30 days, the shares of Achieve Life Sciences Inc (NASDAQ:ACHV) have changed -26.35%. Short interest in the company has seen 2.97 million shares shorted with days to cover at 9.04.
Wall Street analysts have a consensus price target for the stock at $4.75, which means that the shares’ value could jump 44.63% from the levels at last check today.. The projected low price target is $4.0 while the price target rests at a high of $5.5. In that case, then, we find that the latest price level in today’s session is -109.13% off the targeted high while a plunge would see the stock gain -52.09% from the levels at last check today..
Achieve Life Sciences Inc (ACHV) estimates and forecasts
The company’s shares have lost -25.30% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 50.01% over the past 5 years.
ACHV Dividends
Achieve Life Sciences Inc is expected to release its next earnings report on 2025-May-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Achieve Life Sciences Inc (NASDAQ:ACHV)’s Major holders
Insiders own 9.69% of the company shares, while shares held by institutions stand at 41.59% with a share float percentage of 46.05%. Investors are also buoyed by the number of investors in a company, with Achieve Life Sciences Inc having a total of 99.0 institutions that hold shares in the company. The top two institutional holders are FRANKLIN RESOURCES INC with over 6.05 million shares worth more than $19.6 million. As of 2024-06-30, FRANKLIN RESOURCES INC held 17.6358% of shares outstanding.
The other major institutional holder is PROPEL BIO MANAGEMENT, LLC, with the holding of over 2.45 million shares as of 2024-06-30. The firm’s total holdings are worth over $11.53 million and represent 7.148% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND . As of Mar 31, 2025 , the former fund manager holds about 2.96% shares in the company for having 1.03 shares of worth $2.71 million while later fund manager owns 897.27 shares of worth $2.37 million as of Apr 30, 2025 , which makes it owner of about 2.59% of company’s outstanding stock.
